Sonoma Pharmaceuticals (SNOA) Invested Capital (2011 - 2025)

Sonoma Pharmaceuticals' Invested Capital history runs 15 years deep, the most recent figure standing at $3.4 million for Q4 2025.

• In Q4 2025, Invested Capital fell 29.53% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at $3.4 million (down 29.53% YoY), while the FY2025 annual figure was $4.6 million, down 28.31% from the prior year.
• Invested Capital was $3.4 million for Q4 2025 at Sonoma Pharmaceuticals, down from $3.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $11.7 million in Q3 2021 to a low of $3.4 million in Q4 2025.
• Historically, Invested Capital has averaged $6.5 million across 5 years, with a median of $5.9 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Invested Capital plunged 54.09% in 2021, then surged 67.76% in 2022.
• A 5-year view of Invested Capital shows it stood at $11.2 million in 2021, then slumped by 50.23% to $5.6 million in 2022, then climbed by 21.17% to $6.7 million in 2023, then dropped by 27.7% to $4.9 million in 2024, then slipped by 29.53% to $3.4 million in 2025.
• The last three Invested Capital figures came in at $3.4 million (Q4 2025), $3.8 million (Q3 2025), and $4.2 million (Q2 2025), per Business Quant data.